Evidence map›Paper›PMID 34815488›Full record

ArticleScientific reports2021

Multidisciplinary management to optimize outcome of ultrasound-guided high-intensity focused ultrasound (HIFU) in patients with uterine fibroids.

Florian Recker, Marcus Thudium, Holger Strunk, Tolga Tonguc, Sara Dohmen, Guido Luechters, Birgit Bette, Simone Welz, Babak Salam, Kai Wilhelm and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Florian Recker *Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany.
Marcus Thudium *Department of Anaesthesiology, University Hospital Bonn, Bonn, Germany.
Holger StrunkDepartment of Radiology, Städtisches Klinikum Solingen, Solingen, Germany.
Tolga TongucDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Sara DohmenDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Guido LuechtersCenter for Development Research (ZEF), University Bonn, Bonn, Germany.
Birgit BetteDepartment of Anaesthesiology, University Hospital Bonn, Bonn, Germany.
Simone WelzDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Babak SalamDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Kai WilhelmDepartment of Radiology, Johanniter Krankenhaus Bonn, Bonn, Germany.
Eva K EggerDepartment of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany.
Ullrich WüllnerDepartment of Neurology, University Hospital Bonn, Bonn, Germany.
Ulrike AttenbergerDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Alexander MusteaDepartment of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany.
Rupert Conrad *Clinic and Polyclinic for Psychosomatic Medicine and Psychotherapy, University Hospital Bonn, Bonn, Germany.
Milka Marinova *Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany. milka.marinova@ukbonn.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about the specific anaesthesiological and multidisciplinary management of high-intensity focused ultrasound (HIFU) in uterine fibroids. This observational single-center study is the first reporting on an interdisciplinary approach to optimize outcome following ultrasound (US)-guided HIFU in German-speaking countries. A sample of forty patients with symptomatic uterine fibroids was treated by HIFU. Relevant treatment parameters such as total treatment time for intervention, anaesthesia, and sonication time as well as total energy, body temperature, peri-interventional medication and complications were analyzed. Interventional variables did not correlate significantly either with opioid dose or with body temperature. The average fibroid volume reduction rate was 37.8% ± 23.5%, 48.5% ± 22.0% and 70.2% ± 25.5% after 3, 6 and 12 months, respectively. No major anaesthesiological complications occurred apart from an epileptic seizure prior to HIFU treatment in one patient. Peri-procedural hyperthermia (> 37.5 °C) occurred in two patients. Post-procedural two patients experienced a sciatic nerve irritation up to one year; one patient with very large treated fibroid experienced strong short-lasting post-procedural pain. There were two complication-free pregnancies of HIFU-treated patients. Multidisciplinary management is crucial to optimize safety and outcome of US-guided HIFU for uterine fibroids. Peri-procedural pain and temperature management are critical points where an adequate collaboration between anesthesiologist and interventionalist is mandatory.

Indexed as

AdultDisease ManagementFemaleHigh-Intensity Focused Ultrasound AblationHumansLeiomyomaMiddle AgedPatient Care TeamPregnancyRetrospective StudiesTreatment OutcomeUterine Neoplasms

Identifiers

PMID34815488
PMCPMC8611035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.